These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 6381546)
1. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies. Pallesen G; Beverley PC; Lane EB; Madsen M; Mason DY; Stein H J Clin Pathol; 1984 Aug; 37(8):911-8. PubMed ID: 6381546 [TBL] [Abstract][Full Text] [Related]
2. An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues. Norton AJ; Isaacson PG Histopathology; 1986 Dec; 10(12):1243-60. PubMed ID: 3546052 [TBL] [Abstract][Full Text] [Related]
3. In situ immunologic characterization of follicular lymphomas. Ancelin E; Delsol G; Familiades J; Mason DY; Kuhlein E; Al Saati T; Laurent G; Huguet-Rigal F Hematol Oncol; 1984; 2(3):221-37. PubMed ID: 6384007 [TBL] [Abstract][Full Text] [Related]
4. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques. Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of non-Hodgkin's lymphoma with monoclonal antibodies specific for the leucocyte common antigen. Salter DM; Krajewski AS; Dewar AE J Pathol; 1985 Aug; 146(4):345-53. PubMed ID: 2411901 [TBL] [Abstract][Full Text] [Related]
6. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers). Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721 [TBL] [Abstract][Full Text] [Related]
7. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies]. Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412 [TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies. Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody studies in B(non-T)-cell malignancies. Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections. Marder RJ; Variakojis D; Silver J; Epstein AL Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience. Borowitz MJ; Bousvaros A; Brynes RK; Cousar JB; Crissman JD; Whitcomb CC; Kerns BJ; Byrne GE Am J Pathol; 1985 Dec; 121(3):514-21. PubMed ID: 2933960 [TBL] [Abstract][Full Text] [Related]
12. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas. Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576 [TBL] [Abstract][Full Text] [Related]
13. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas. Borowitz MJ; Croker BP; Metzgar RS Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233 [TBL] [Abstract][Full Text] [Related]
15. Distribution of the Burkitt's lymphoma-associated antigen (BLA) in normal human tissue and malignant lymphoma as defined by immunohistological staining with monoclonal antibody 38.13. Pallesen G; Zeuthen J J Cancer Res Clin Oncol; 1987; 113(1):78-86. PubMed ID: 3546331 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies. Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430 [TBL] [Abstract][Full Text] [Related]
17. The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Doggett RS; Wood GS; Horning S; Levy R; Dorfman RF; Bindl J; Warnke RA Am J Pathol; 1984 May; 115(2):245-52. PubMed ID: 6232854 [TBL] [Abstract][Full Text] [Related]
18. Analysis of large-cell lymphomas using monoclonal and heterologous antibodies. van der Valk P; van den Besselaar-Dingjan G; Daha MR; Meijer CJ J Clin Pathol; 1983 Jan; 36(1):44-50. PubMed ID: 6337190 [TBL] [Abstract][Full Text] [Related]
19. Distribution of HNK-1+ cells in malignant lymphomas. Mori S; Yamaguchi K; Morita H; Mohri N Acta Pathol Jpn; 1985 Mar; 35(2):339-50. PubMed ID: 3895822 [TBL] [Abstract][Full Text] [Related]
20. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance]. Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]